The World Trade Organisation establishes the rules of global trade and reduces tariffs. It also sets multilateral minimum standards for the protection of intellectual property rights, which all member states must comply with.
The World Trade Organisation (WTO) was founded in 1995 and is based in Geneva. By reducing tariffs and setting out rules for trade between its 164 member states (as at 2016), it aims to promote global trade and thereby economic growth and prosperity. The WTO combines three key trade agreements:
- GATT (General Agreement on Tariffs and Trade, merchandise trade);
- GATS (General Agreement on Trade in Services, trade of services);
- TRIPS (Trade-related Aspects of Intellectual Property Agreement).
The TRIPS Agreement of the World Trade Organization (WTO) was revised on 23 January 2017. The revision of the agreement provides poorer WTO members with access to generic drugs. This change is in particular important for those countries that do not have their own pharmaceutical industry. This is the first revision of a WTO agreement since the organisation was created in 1995. Switzerland had already ratified the amendment on 13 September 2006, being the second country worldwide to do so, and has provided for the possibility of a compulsory license for the export of medicines under the Swiss Patents Act since 1 July 2008.
The TRIPS Agreements sets out multilateral minimum standards for all key areas of intellectual property:
- Copyright and related rights
- Trade marks for goods and services
- Geographical indications
- Layout-Design (Topographies) of integrated circuits
- Undisclosed information (among which trade and manufacturing secrets).
In addition, it contains important rules on procedural law, law enforcement and border measures to combat counterfeiting and piracy. As part of the WTO's body of regulations, it is also subject to the WTO dispute settlement procedure.
The TRIPS Council consists of all WTO members. It administers the TRIPS Agreement, reviews its implementation by member states and discusses important questions in connection with trade-related aspects of intellectual property rights, such as:
- How does the TRIPS Agreement affect access to medicines?
- How can geographical indications be better protected?
- How can biopiracy be prevented through the patent system?
- How can the protection of intellectual property boost innovation and development?
The Council also discusses and coordinates technical cooperation and technology transfer between developed and less developed countries.
- We play an active and committed part in the work of the WTO
- We lead the Swiss delegation at TRIPS Council meetings
- We coordinate Switzerland's position in close collaboration with the State Secretariat for Economic Affairs (SECO), the Swiss Mission in Geneva and other involved administrative agencies and external stakeholders
06.07.2018 | IPI
The founding of the sic! Foundation for intellectual property, information and competition law.
08.06.2018 | IP news
Winners of the European Inventor Award 2018 announced: The Swiss physicist Ursula Keller receives lifetime achievement award
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office